The overall objective of this research project is to understand the mechanism by which carcinogenic chromium(VI) compounds affect gene expression. The approaches we plan to use in attacking this problem are: (1) examine the ability of chromium (VI to differentially affect gene expression in 14 day chick embryos, a simple well-defined in vivo system; (2) compare the effects of chromium (VI) on model genes which have different types of general and specific regulatory elements (GC- boxes, glucocorticoid responsive elements (GREs), cAMP-responsive elements, and metal responsive elements (MREs), and respective specific transcription factors (AP1,SP1, glucocorticoid receptor, cAMP-binding protein, and metal-activated factors): and (3) determine the effect of chromium (VI) on the normal binding of transcription factors to their recognition sequences. Chromium (VI) compounds have been shown to preferentially attack specific DNA sequences and to differentially affect the transcription of inducible vs. non-inducible genes. Therefore, we plan to test the hypothesis that chromium (VI)-induced DNA damage affects gene expression by altering the interaction of transcription factors with promoter regions of the gene. Specifically we propose to test the hypothesis that chromium (VI) interferes with the normal interaction of regulatory protein within the controlling regions of inducible genes and not those of other constitutive genes.
The specific aims of the proposed research are: (1) The effects of chromium (VI)-induced DNA damage on the constitutive and inducible steady-state mRNA levels and transcription rates of metallothionein, phosphoenolpyruvate carboxykinase, and albumin genes will be determined in the liver of chick embryos treated with chromium (VI) in vivo. The effects of chromium (VI) treatment on the basal and inducible steady- state levels of expression of these genes will be determined by solution hybridization and Northern blot analyses. The effects of chromium (VI) on the basal and inducible rates of transcription of these genes will be determined by nuclear """"""""run-off"""""""" transcription assays. (2) The effect of chromium (VI)-induced DNA damage on the interaction of transcription factors with the promoter regions of the metallothionein, phosphoenolpyruvate carboxykinase, and albumin genes will be determined in the liver of 14 day chick embryos treated with chromium (VI) in vivo. The DNA-protein interactions in vivo will be determined using ligation- mediated polymerase chain reaction (PCR)-based genomic footprinting analysis of the promoter regions of these genes. The long-range objective of this research project is to understand the mechanism by which chromium (VI) compounds act as carcinogens. The proposed studies should provide evidence for differential effects of chromium (VI) on important regulatory regions of genes and elucidate critical effects on DNA structure and function, and thus, provide insight into the mechanism by which chromium (VI) initiates cancer. This, in turn, could provide fundamental insights into the overall mechanism of initiation of the neoplastic process by genotoxic carcinogens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA045735-04A1
Application #
3188978
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1991-09-30
Project End
1994-07-31
Budget Start
1991-09-30
Budget End
1992-07-31
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Arts and Sciences
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Shumilla, J A; Wetterhahn, K E; Barchowsky, A (1998) Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. Arch Biochem Biophys 349:356-62
Dubrovskaya, V A; Wetterhahn, K E (1998) Effects of Cr(VI) on the expression of the oxidative stress genes in human lung cells. Carcinogenesis 19:1401-7
Martin, B D; Schoenhard, J A; Sugden, K D (1998) Hypervalent chromium mimics reactive oxygen species as measured by the oxidant-sensitive dyes 2',7'-dichlorofluorescin and dihydrorhodamine. Chem Res Toxicol 11:1402-10
Alcedo, J A; Misra, M; Hamilton, J W et al. (1994) The genotoxic carcinogen chromium(VI) alters the metal-inducible expression but not the basal expression of the metallothionein gene in vivo. Carcinogenesis 15:1089-92
Hamilton, J W; Bement, W J; Sinclair, P R et al. (1992) Inhibition of protein synthesis increases the transcription of the phenobarbital-inducible CYP2H1 and CYP2H2 genes in chick embryo hepatocytes. Arch Biochem Biophys 298:96-104
Aiyar, J; De Flora, S; Wetterhahn, K E (1992) Reduction of chromium(VI) to chromium(V) by rat liver cytosolic and microsomal fractions: is DT-diaphorase involved? Carcinogenesis 13:1159-66
Borges, K M; Wetterhahn, K E (1991) Chromium bound to DNA alters cleavage by restriction endonucleases. Chem Res Toxicol 4:638-41
Hamilton, J W; Bement, W J; Sinclair, P R et al. (1991) Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch Biochem Biophys 289:387-92
Borges, K M; Boswell, J S; Liebross, R H et al. (1991) Activation of chromium(VI) by thiols results in chromium(V) formation, chromium binding to DNA and altered DNA conformation. Carcinogenesis 12:551-61
Aiyar, J; Berkovits, H J; Floyd, R A et al. (1991) Reaction of chromium(VI) with glutathione or with hydrogen peroxide: identification of reactive intermediates and their role in chromium(VI)-induced DNA damage. Environ Health Perspect 92:53-62

Showing the most recent 10 out of 17 publications